• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[巴西的多重耐药结核病:历史与防控]

[Multiresistant tuberculosis in Brazil: history and control].

作者信息

Dalcolmo Margareth Pretti, Andrade Mônica Kramer de Noronha, Picon Pedro Dornelles

机构信息

Centro de Referência Hélio Fraga, Ministério da Saúde, Rio de Janeiro, RJ, Brazil.

出版信息

Rev Saude Publica. 2007 Sep;41 Suppl 1:34-42. doi: 10.1590/s0034-89102007000800006.

DOI:10.1590/s0034-89102007000800006
PMID:18038089
Abstract

The article aimed at assessing multidrug-resistant tuberculosis control in Brazil, based on the experiences of reference institutions, and the most relevant studies carried out to determine local and national resistance rates. Control measures and the current situation of treatment and diagnoses after the implementation of the national guidelines, which were revised in 2004, are considered. The first national survey on resistance to anti-tuberculosis drugs was performed in the middle of last decade. From its outcomes, a regimen to treat all cases of multidrug-resistant tuberculosis was validated and adopted. Government measures enabled the implementation of a surveillance system, whose outcomes are also commented.

摘要

本文旨在基于参考机构的经验以及为确定当地和全国耐药率而开展的最相关研究,评估巴西的耐多药结核病控制情况。文中考虑了2004年修订的国家指南实施后的控制措施以及治疗和诊断的现状。上世纪九十年代中期开展了首次全国抗结核药物耐药性调查。根据调查结果,验证并采用了一种治疗所有耐多药结核病病例的方案。政府采取的措施促成了一个监测系统的实施,文中也对该系统的结果进行了评论。

相似文献

1
[Multiresistant tuberculosis in Brazil: history and control].[巴西的多重耐药结核病:历史与防控]
Rev Saude Publica. 2007 Sep;41 Suppl 1:34-42. doi: 10.1590/s0034-89102007000800006.
2
Multidrug resistant tuberculosis.耐多药结核病
Indian Pediatr. 1998 Aug;35(8):715-8.
3
[Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].新发肺结核患者中结核分枝杆菌的耐药性
Probl Tuberk Bolezn Legk. 2005(12):37-9.
4
Challenges and Outlooks in Multi-drug Resistant Tuberculosis.耐多药结核病的挑战与展望
Arch Bronconeumol. 2017 Aug;53(8):417-418. doi: 10.1016/j.arbres.2017.01.018. Epub 2017 Mar 14.
5
[Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].2000年塔那那利佛结核分枝杆菌对抗结核药物的耐药性
Arch Inst Pasteur Madagascar. 2002;68(1-2):44-7.
6
[Isoniazid and rifampicin resistance and prior treatment for tuberculosis].[异烟肼和利福平耐药性以及结核病的既往治疗情况]
Cad Saude Publica. 2003 Sep-Oct;19(5):1277-81. doi: 10.1590/s0102-311x2003000500006. Epub 2003 Dec 2.
7
[Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].[肺结核患者对利福平和异烟肼的同时耐药性]
Rev Mal Respir. 2000 Apr;17(2):477-80.
8
[Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis].[微芯片技术在结核分枝杆菌耐药性检测中的临床价值]
Probl Tuberk. 2002(6):21-4.
9
[Drug-resistant pulmonary tuberculosis at the penitentiaries].[监狱中的耐多药肺结核]
Probl Tuberk Bolezn Legk. 2008(12):60-3.
10
Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.印度古吉拉特邦既往治疗过的结核病患者的耐药性研究。
Int J Tuberc Lung Dis. 2002 Dec;6(12):1098-101.

引用本文的文献

1
Management of multidrug-resistant tuberculosis: main recommendations of the Brazilian guidelines.耐多药结核病的管理:巴西指南的主要建议。
J Bras Pneumol. 2020;46(2):e20190290. doi: 10.36416/1806-3756/e20190290. Epub 2020 May 11.
2
Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016.巴西里约热内卢州 2000-2016 年耐多药和广泛耐药结核患者不良治疗结局的预测因素。
PLoS One. 2019 Nov 20;14(11):e0218299. doi: 10.1371/journal.pone.0218299. eCollection 2019.
3
Predictors of mortality in multidrug-resistant tuberculosis patients from Brazilian reference centers, 2005 to 2012.
2005 年至 2012 年巴西参考中心耐多药结核病患者死亡的预测因素。
Braz J Infect Dis. 2018 Jul-Aug;22(4):305-310. doi: 10.1016/j.bjid.2018.07.002. Epub 2018 Aug 6.
4
Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis.序贯分析作为检测阿米卡星在耐多药结核病治疗中耳毒性的一种工具。
J Bras Pneumol. 2018 Apr;44(2):85-92. doi: 10.1590/s1806-37562016000000312.
5
Risk factors associated with multidrug-resistant tuberculosis in Espírito Santo, Brazil.巴西圣埃斯皮里图州耐多药结核病的相关危险因素。
Rev Saude Publica. 2017 Apr 27;51(0):41. doi: 10.1590/S1518-8787.2017051006688.
6
Path of infectious diseases in Brazil in the last 50 years: an ongoing challenge.巴西过去50年传染病的传播路径:一项持续存在的挑战。
Rev Saude Publica. 2016 Dec 22;50:68. doi: 10.1590/S1518-8787.2016050000232.
7
Profile and follow-up of patients with tuberculosis in a priority city in Brazil.巴西一个重点城市结核病患者的概况及随访情况
Rev Saude Publica. 2015;49:6. doi: 10.1590/s0034-8910.2015049005304. Epub 2015 Feb 27.
8
Multidrug resistant Mycobacterium tuberculosis: a retrospective katG and rpoB mutation profile analysis in isolates from a reference center in Brazil.多重耐药结核分枝杆菌:巴西一家参考中心分离株中katG和rpoB基因突变谱的回顾性分析
PLoS One. 2014 Aug 5;9(8):e104100. doi: 10.1371/journal.pone.0104100. eCollection 2014.
9
Viability of stressed Mycobacterium tuberculosis and association with multidrug resistance.压力下结核分枝杆菌的活力及其与耐多药的关系。
Braz J Microbiol. 2013 Oct 30;44(2):465-8. doi: 10.1590/S1517-83822013000200019. eCollection 2013.
10
Multidrug-resistant tuberculosis.耐多药结核病。
Braz J Infect Dis. 2013 Mar-Apr;17(2):239-46. doi: 10.1016/j.bjid.2013.01.007. Epub 2013 Mar 9.